Esophageal Cancer

Contact: CancerResearch@VirginiaMason.org or (206) 342-6954

Clinical StudiesDiagnosis
Non-MetastaticMetastaticPreviously TreatedTreatment Naive

Temporal Variation in Exhaled Volatile Organic Compounds in Response to Therapeutic Intervention in Esophageal Cancer Patients 

  
Evaluation of the Lasting Symptons After Esophageal Resection (LASER) questionnaire in esophageal disease
Phase 2 Study of ZW25 Plus First-line Combination Chemotherapy in HER2-Expressing Gastroesophageal Adenocarcinoma (GEA) 

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

  
VM BRITE: A Tissue Registry and Specimen Repository to Support Future Research Projects